OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+30.02%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$201M
AUM Growth
+$31.2M
(+18%)
Cap. Flow
+$5.18M
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
56.18%
Holding
53
New
12
Increased
15
Reduced
7
Closed
9
Top Buys
| 1 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$7.84M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$6.21M |
| 3 |
Ocular Therapeutix
OCUL
|
$4.24M |
| 4 |
CytomX Therapeutics
CTMX
|
$2.94M |
| 5 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
$2.38M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$12.4M |
| 2 |
Neurogene
NGNE
|
$3.75M |
| 3 |
MacroGenics
MGNX
|
$3.48M |
| 4 |
Omeros
OMER
|
$2.63M |
| 5 |
Clearside Biomedical
CLSD
|
$2.41M |
Sector Composition
| 1 | Healthcare | 92.1% |